{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:31:10Z","timestamp":1787761870142,"version":"build-2784847793"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>AIM:<\/jats:title>\n                    <jats:p>This study aims to evaluate the treatment outcomes of periocular capillary hemangioma with oral propranolol (OP) and list the factors predictive of recurrence and incomplete resolution after treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODOLOGY:<\/jats:title>\n                    <jats:p>\n                      Data were collected by retrospective review of medical files of patients with infantile hemangioma (IH) treated with OP during January 2014\u2013December 2019 from two tertiary eye institutes from India. Patients presenting with symptoms of IH with\/without any history of prior treatment were included. All patients were started on OP with the dose of 2\u20132.5 mg\/Kg body weight and continued till complete resolution or till the lesion reached a plateau response. Details about the ophthalmic examination at each visit and availability of imaging findings were noted down from the records. Primary outcome: Study the treatment outcome of patients treated with OP and discussed our observations regarding factors that may predict nonresponse, poor response, or recurrence. Secondary outcome: complications\/side effects of therapy. Response to treatment was judged as fair, good, and excellent depending on resolution &lt;50%, &gt;50%, and complete resolution, respectively. Univariate analysis of factors related to treatment response was judged as fair, good, and excellent depending on resolution &lt;50%, &gt;50%, outcome and recurrence was studied using Mann\u2013Whitney\n                      <jats:italic toggle=\"yes\">U<\/jats:italic>\n                      test and Fisher's exact test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 28 patients were included in the study, out of which 17 were female and 11 were male. The mean age of onset of the lesion was 1.08 (\u00b1 1.484) months, 11 being congenital in origin. The mean age at presentation was 4.15 (\u00b1 2.92) months. 46.43% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 13) of patients showed complete resolution, while 25% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 7) showed more than 50% reduction in lesion size. Fair response was noted in 28.57% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 8). The mean duration of follow-up after stopping OP was 17.7 (\u00b1 20.774) months. The recurrence rate noted was 14.28%. The factors which were associated with incomplete resolution were age at presentation &gt;3 months, later age of appearance of the lesion, superficial lesions with no orbital involvement. Male gender and congenital lesions responded best to OP therapy. Minor complications were noted with a rate of 25% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 7). Younger age at presentation was more commonly associated with complications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>OP is a safe and effective treatment for capillary hemangioma except for a smaller subset of patients who show suboptimal response to this drug. However, specific factors responsible for suboptimal response or recurrence after OP therapy remain elusive. Although not statistically significant, there was an increasing trend toward higher age at presentation, low birth weight, and superficial lesions with a poorer response. Furthermore, these factors along with the male gender were commonly associated with recurrence in our series. Larger prospective studies focused on evaluating clinical factors responsible for incomplete resolution and recurrence will help in prognosticating and suggesting alternative treatment regimes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ojo.ojo_11_22","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T02:50:51Z","timestamp":1676947851000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Treatment outcomes of oral propranolol in the treatment of periocular infantile capillary hemangioma and factors predictive of recurrence and incomplete resolution"],"prefix":"10.4103","volume":"16","author":[{"given":"Sweety","family":"Tiple","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prajakta","family":"Kimmatkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sima","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alankrita","family":"Muralidhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Nehashree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayush","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Patidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elesh","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20240908","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1542\/peds.2014-3673","article-title":"Vascular anomalies classification: Recommendations from the international society for the study of vascular anomalies","volume":"136","author":"Wassef","year":"2015","journal-title":"Pediatrics"},{"key":"R2-16-20240908","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jpeds.2012.02.052","article-title":"A prospective study of cutaneous findings in newborns in the United States: Correlation with race, ethnicity, and gestational status using updated classification and nomenclature","volume":"161","author":"Kanada","year":"2012","journal-title":"J Pediatr"},{"key":"R3-16-20240908","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/bjd.12435","article-title":"Pathogenesis of infantile haemangioma","volume":"169","author":"Greenberger","year":"2013","journal-title":"Br J Dermatol"},{"key":"R4-16-20240908","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4103\/jovr.jovr_201_16","article-title":"Orbital volume augmentation with calcium hydroxyapatite filler in anophthalmic enophthalmos","volume":"12","author":"Aletaha","year":"2017","journal-title":"J Ophthalmic Vis Res"},{"key":"R5-16-20240908","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1542\/peds.2007-2767","article-title":"Growth characteristics of infantile hemangiomas: Implications for management","volume":"122","author":"Chang","year":"2008","journal-title":"Pediatrics"},{"key":"R6-16-20240908","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1542\/peds.2011-3683","article-title":"Early growth of infantile hemangiomas: What parents' photographs tell us","volume":"130","author":"Tollefson","year":"2012","journal-title":"Pediatrics"},{"key":"R7-16-20240908","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1053\/j.sempedsurg.2014.06.017","article-title":"Infantile and congenital hemangiomas","volume":"23","author":"Liang","year":"2014","journal-title":"Semin Pediatr Surg"},{"key":"R8-16-20240908","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jaad.2003.10.670","article-title":"Congenital hemangiomas and infantile hemangioma: Missing links","volume":"50","author":"Mulliken","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"R9-16-20240908","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ajo.2017.10.021","article-title":"Clinical and radiological evaluation of periocular infantile hemangioma treated with oral propranolol: A case series","volume":"185","author":"Ginguerra","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"R10-16-20240908","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.ultrasmedbio.2014.06.021","article-title":"Ultrasound in assessing the efficacy of propranolol therapy for infantile hemangiomas","volume":"40","author":"Shi","year":"2014","journal-title":"Ultrasound Med Biol"},{"key":"R11-16-20240908","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bjps.2010.08.039","article-title":"Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution","volume":"64","author":"Itinteang","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R12-16-20240908","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000489956","article-title":"\u03b2-adrenoceptor blockade for infantile hemangioma therapy: Do \u03b23-adrenoceptors play a role?","volume":"55","author":"Escarcega Gonz\u00e1lez","year":"2018","journal-title":"J Vasc Res"},{"key":"R13-16-20240908","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0974-9233.63071","article-title":"Periocular capillary hemangiomas: Indications and options for treatment","volume":"17","author":"Bang","year":"2010","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R14-16-20240908","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3928\/01913913-20101018-02","article-title":"New developments in the management of periocular capillary hemangioma in children","volume":"48","author":"Ni","year":"2011","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R15-16-20240908","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/bjo.2010.192245","article-title":"The use of propranolol in the treatment of periocular infantile haemangiomas: A review","volume":"95","author":"Claerhout","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R16-16-20240908","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaapos.2010.05.002","article-title":"Outpatient treatment of periocular infantile hemangiomas with oral propranolol","volume":"14","author":"Haider","year":"2010","journal-title":"J AAPOS"},{"key":"R17-16-20240908","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/eye.2011.233","article-title":"Refractive and structural changes in infantile periocular capillary haemangioma treated with propranolol","volume":"25","author":"Snir","year":"2011","journal-title":"Eye (Lond"},{"key":"R18-16-20240908","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/eye.2011.164","article-title":"The use of propranolol in the management of periocular capillary haemangioma \u2013 A systematic review","volume":"25","author":"Spiteri Cornish","year":"2011","journal-title":"Eye (Lond"},{"key":"R19-16-20240908","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/ICU.0000000000000591","article-title":"\u03b2-blockers in the treatment of periocular infantile hemangioma","volume":"30","author":"Al-Haddad","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"key":"R20-16-20240908","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4103\/0974-9233.90131","article-title":"Oral propranolol for the treatment of periorbital infantile hemangioma: A preliminary report from oman","volume":"18","author":"Harikrishna","year":"2011","journal-title":"Middle East Afr J Ophthalmol"},{"key":"R21-16-20240908","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2147\/OPTH.S39029","article-title":"Periocular capillary hemangioma: Management practices in recent years","volume":"7","author":"Hernandez","year":"2013","journal-title":"Clin Ophthalmol"},{"key":"R22-16-20240908","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.pedneo.2017.11.021","article-title":"Effect of oral propranolol on periocular Capillary Hemangiomas of Infancy","volume":"59","author":"Koka","year":"2018","journal-title":"Pediatr Neonatol"},{"key":"R23-16-20240908","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/IOP.0b013e318201d344","article-title":"Propranolol for the treatment of orbital infantile hemangiomas","volume":"27","author":"Fridman","year":"2011","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R24-16-20240908","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1442-9071.2010.02327.x","article-title":"Successful treatment of infantile haemangiomas of the orbit with propranolol","volume":"38","author":"Li","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"R25-16-20240908","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ophtha.2009.08.040","article-title":"Propranolol for orbital hemangioma","volume":"117","author":"Taban","year":"2010","journal-title":"Ophthalmology"},{"key":"R26-16-20240908","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.ophtha.2010.10.031","article-title":"Treatment of periocular infantile hemangiomas with propranolol: Case series of 18 children","volume":"118","author":"Al Dhaybi","year":"2011","journal-title":"Ophthalmology"},{"key":"R27-16-20240908","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1525-1470.2009.00975.x","article-title":"Propranolol treatment for hemangioma of infancy: Risks and recommendations","volume":"26","author":"Lawley","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"R28-16-20240908","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1525-1470.2010.01224.x","article-title":"Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: A case report","volume":"28","author":"Breur","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"R29-16-20240908","doi-asserted-by":"crossref","first-page":"43292","DOI":"10.1038\/srep43292","article-title":"When to stop propranolol for infantile hemangioma","volume":"7","author":"Chang","year":"2017","journal-title":"Sci Rep"},{"key":"R30-16-20240908","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/SAP.0000000000000506","article-title":"Is propranolol safe and effective for outpatient use for infantile hemangioma? A prospective study of 679 cases from one center in China","volume":"76","author":"Chang","year":"2016","journal-title":"Ann Plast Surg"},{"key":"R31-16-20240908","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/pde.12190","article-title":"Late rebound of infantile hemangioma after cessation of oral propranolol","volume":"30","author":"Shehata","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"R32-16-20240908","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.bjps.2010.06.010","article-title":"Low-dose propranolol for infantile haemangioma","volume":"64","author":"Tan","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R33-16-20240908","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4103\/jiaps.JIAPS_12_18","article-title":"Oral propranolol in infantile hemangiomas: Analysis of factors that affect the outcome","volume":"24","author":"Ainipully","year":"2019","journal-title":"J Indian Assoc Pediatr Surg"},{"key":"R34-16-20240908","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1038\/s41598-018-22787-8","article-title":"Intolerable side effects during propranolol therapy for infantile hemangioma: Frequency, risk factors and management","volume":"8","author":"Ji","year":"2018","journal-title":"Sci Rep"}],"container-title":["Oman Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_11_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:06:44Z","timestamp":1787760404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ojo.ojo_11_22"}},"subtitle":["A multi-centric study"],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ojo.ojo_11_22","relation":{},"ISSN":["0974-620X"],"issn-type":[{"value":"0974-620X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}